Vince Lahey of Carefree, Arizona, embraces chatbots. From Big Tech products to "shady" ones, they offer "someone that I could share more secrets with than my therapist." ...

Millions of people who apply for Medicaid in the coming years will have to prove they've been working, going to school, or ...

The number of babies born in the United States fell again last year. According to new data from the Centers for Disease ...

Design and optimize cardiometabolic trials by addressing complexity, endpoints, recruitment, and regulatory requirements.

Discover common misconceptions in renal and hepatic impairment studies and how expert teams navigate complexity in drug development.

Obesity trials are evolving toward chronic disease models with improved endpoints, longer study designs, and greater clinical ...

A study reveals how childhood flu infections impact long-term mortality risk, highlighting implications for vaccination and ...

Explore how evolving obesity research is shaping trial design, with a focus on precision, reproducibility, and clinical ...

TF: GLP-1s were first discovered as therapies for type 2 diabetes, and their weight-loss properties were practically a bonus.

Children born to mothers who used buprenorphine for opioid addiction during pregnancy do not have a greater risk of ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a global public health challenge with rapidly ...

Expanding access to NHS Talking Therapies may help reduce the long-term economic inactivity faced by people with entrenched mental health problems, University of Manchester researchers say.